-
effectivehealthcare.ahrq.gov/products/stroke-afib-update/research-protocol
July 07, 2017 - Newer anticoagulants (direct oral anticoagulants [DOACs]) resulted in reduced stroke and bleeding events … Procedural interventions
Procedural interventions for stroke prophylaxis have emerged and are growing … with AF are uncertain
There is a lack of information to guide decisions regarding the best specific anticoagulant … Oral Anticoagulant Prescription in Patients With Atrial Fibrillation and a Low Risk of Thromboembolism … pradaxa[tiab] OR heparin[tiab] OR apixaban[tiab] OR eliquis[tiab] OR edoxaban[tiab] OR lixiana[tiab] OR anticoagulant
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/vte-prophyalaxis_executive.pdf
May 01, 2013 - Similarly, we included antiplatelet agents aspirin and
clopidogrel; as well as the anticoagulant warfarin … We also
included dabigatran, a recently approved oral anticoagulant
that directly inhibits thrombin … A study
of extended prophylaxis versus inpatient prophylaxis
suggested that continuing enoxaparin therapy … Rare events such as bleeding
from prophylactic doses of anticoagulant are difficult to
answer in trials … Parenteral anticoagulants:
Antithrombotic Therapy and Prevention of Thrombosis, 9th ed:
American College
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/vte-prophyalaxis_executive.pdf
May 01, 2013 - Similarly, we included antiplatelet agents aspirin and
clopidogrel; as well as the anticoagulant warfarin … We also
included dabigatran, a recently approved oral anticoagulant
that directly inhibits thrombin … A study
of extended prophylaxis versus inpatient prophylaxis
suggested that continuing enoxaparin therapy … Rare events such as bleeding
from prophylactic doses of anticoagulant are difficult to
answer in trials … Parenteral anticoagulants:
Antithrombotic Therapy and Prevention of Thrombosis, 9th ed:
American College
-
ahrqpubs.ahrq.gov/research/findings/studies/index.html?page=4
January 01, 2024 - did not reduce clinically important medication errors for ambulatory patients initiating direct oral anticoagulants … The primary measure was anticoagulant-related CIMEs and non-anticoagulant-related CIMEs over 90 days … There was no reduction in anticoagulant-related CIMEs among intervention patients or non-anticoagulant-related … did not reduce clinically important medication errors for ambulatory patients initiating direct oral anticoagulants … Preexposure prophylaxis to prevent acquisition of HIV.
Am Fam Physician 2023 Dec; 108(6):617-18..
-
healthcare411.ahrq.gov/research/findings/studies/index.html?page=4
January 01, 2024 - did not reduce clinically important medication errors for ambulatory patients initiating direct oral anticoagulants … The primary measure was anticoagulant-related CIMEs and non-anticoagulant-related CIMEs over 90 days … There was no reduction in anticoagulant-related CIMEs among intervention patients or non-anticoagulant-related … did not reduce clinically important medication errors for ambulatory patients initiating direct oral anticoagulants … Preexposure prophylaxis to prevent acquisition of HIV.
Am Fam Physician 2023 Dec; 108(6):617-18..
-
cahps.ahrq.gov/research/findings/studies/index.html?page=4
January 01, 2024 - did not reduce clinically important medication errors for ambulatory patients initiating direct oral anticoagulants … The primary measure was anticoagulant-related CIMEs and non-anticoagulant-related CIMEs over 90 days … There was no reduction in anticoagulant-related CIMEs among intervention patients or non-anticoagulant-related … did not reduce clinically important medication errors for ambulatory patients initiating direct oral anticoagulants … Preexposure prophylaxis to prevent acquisition of HIV.
Am Fam Physician 2023 Dec; 108(6):617-18..
-
monahrq.ahrq.gov/research/findings/studies/index.html?page=4
January 01, 2024 - did not reduce clinically important medication errors for ambulatory patients initiating direct oral anticoagulants … The primary measure was anticoagulant-related CIMEs and non-anticoagulant-related CIMEs over 90 days … There was no reduction in anticoagulant-related CIMEs among intervention patients or non-anticoagulant-related … did not reduce clinically important medication errors for ambulatory patients initiating direct oral anticoagulants … Preexposure prophylaxis to prevent acquisition of HIV.
Am Fam Physician 2023 Dec; 108(6):617-18..
-
patientregistry.ahrq.gov/research/findings/studies/index.html?page=4
January 01, 2024 - did not reduce clinically important medication errors for ambulatory patients initiating direct oral anticoagulants … The primary measure was anticoagulant-related CIMEs and non-anticoagulant-related CIMEs over 90 days … There was no reduction in anticoagulant-related CIMEs among intervention patients or non-anticoagulant-related … did not reduce clinically important medication errors for ambulatory patients initiating direct oral anticoagulants … Preexposure prophylaxis to prevent acquisition of HIV.
Am Fam Physician 2023 Dec; 108(6):617-18..
-
talkingquality.ahrq.gov/research/findings/studies/index.html?page=4
January 01, 2024 - did not reduce clinically important medication errors for ambulatory patients initiating direct oral anticoagulants … The primary measure was anticoagulant-related CIMEs and non-anticoagulant-related CIMEs over 90 days … There was no reduction in anticoagulant-related CIMEs among intervention patients or non-anticoagulant-related … did not reduce clinically important medication errors for ambulatory patients initiating direct oral anticoagulants … Preexposure prophylaxis to prevent acquisition of HIV.
Am Fam Physician 2023 Dec; 108(6):617-18..
-
psnet.ahrq.gov/node/866995/psn-pdf
October 30, 2024 - their response to unfractionated
heparin—with some patients requiring large doses to achieve adequate prophylaxis … or
activated factor X levels, has been proposed as a means to monitor the effectiveness of heparin
prophylaxis … injured patients, ordering clinicians must carefully weigh the risks and benefits of
pharmacologic prophylaxis … Early pharmacological venous thromboembolism prophylaxis
is safe after operative fixation of traumatic
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/stroke-afib-update_research-protocol-amended.pdf
October 27, 2017 - Newer anticoagulants (direct oral
anticoagulants [DOACs]) resulted in reduced stroke and bleeding events … of studies have examined the appropriate populations and appropriate
therapies for adequate stroke prophylaxis … Procedural interventions Procedural interventions for stroke prophylaxis have emerged and
are growing … AF are uncertain
• There is a lack of information to guide decisions regarding the best specific
anticoagulant … Oral Anticoagulant Prescription in Patients With Atrial
Fibrillation and a Low Risk of Thromboembolism
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/stroke-afib-update_research-protocol-amended.pdf
October 27, 2017 - Newer anticoagulants (direct oral
anticoagulants [DOACs]) resulted in reduced stroke and bleeding events … of studies have examined the appropriate populations and appropriate
therapies for adequate stroke prophylaxis … Procedural interventions Procedural interventions for stroke prophylaxis have emerged and
are growing … AF are uncertain
• There is a lack of information to guide decisions regarding the best specific
anticoagulant … Oral Anticoagulant Prescription in Patients With Atrial
Fibrillation and a Low Risk of Thromboembolism
-
psnet.ahrq.gov/node/49656/psn-pdf
June 01, 2012 - Who is responsible for routine patient safety measures, such as deep venous thrombosis
prophylaxis? … Because of
the risk of central nervous system bleeding, anticoagulant use is a shared responsibility—hospitalists … always contact neurosurgery physicians before starting antiplatelet or anticoagulant agents.
-
ce.effectivehealthcare.ahrq.gov/news/newsroom/case-studies/ktcquips98.html
October 01, 2014 - As a result, prevalence of appropriate VTE prophylaxis increased from 55 to 100 percent for surgical … prophylaxis and 100 percent for patients admitted to the hospitalist service between March and August … As a result of these interventions, appropriate VTE prophylaxis increased from 0 to 100 percent, and … The dashboard appears in green if the patient is on pharmacological prophylaxis, in yellow if the patient … is on sequential compression devices or if a contraindication is documented, and in red if VTE prophylaxis
-
digital.ahrq.gov/health-it-tools-and-resources/health-it-costs-and-benefits-database/clinical-decision-support-system
June 07, 2000 - Purpose of Study: Determine whether presentation of venous thromboembolism prophylaxis guidelines using
-
effectivehealthcare-admin.ahrq.gov/health-topics/carbohydrates?page=1
May 29, 2013 - Products
Systematic Review Archived May 29, 2013
Pharmacologic and Mechanical Prophylaxis … difficile Infection
Systematic Review Archived March 13, 2012
Venous Thromboembolism Prophylaxis … Protocol Archived January 12, 2012
Comparative Effectiveness of Pharmacologic and Mechanical Prophylaxis … Protocol Archived August 6, 2010
Comparative Effectiveness of Venous Thromboembolism (VTE) Prophylaxis
-
psnet.ahrq.gov/issue/automatic-detection-omissions-medication-lists
December 31, 2014 - December 7, 2011
Modes of failure in venous thromboembolism prophylaxis. … December 16, 2020
WebM&M Cases
Direct Oral Anticoagulants
-
pbrn.ahrq.gov/hai/tools/surgery/modules/implementation/audit-briefing-slides.html
December 01, 2017 - Bleeding concerns (e.g., anticoagulant use).
Blood availability.
Allergies. … Deep vein thrombosis prophylaxis.
Warmers.
Lab/radiology review. … Deep vein thrombosis (DVT) prophylaxis - 100% Yes.
Glycemic control - 40% Yes. … Anticoagulant use - 10% Yes.
Access issues - 20% Yes.
Airway risk - 20% Yes.
-
pcmh.ahrq.gov/hai/tools/surgery/modules/implementation/audit-briefing-slides.html
December 01, 2017 - Bleeding concerns (e.g., anticoagulant use).
Blood availability.
Allergies. … Deep vein thrombosis prophylaxis.
Warmers.
Lab/radiology review. … Deep vein thrombosis (DVT) prophylaxis - 100% Yes.
Glycemic control - 40% Yes. … Anticoagulant use - 10% Yes.
Access issues - 20% Yes.
Airway risk - 20% Yes.
-
www.ahrq.gov/sites/default/files/2024-07/rothberg-report.pdf
January 01, 2024 - rate of prophylaxis is high but the rate of inappropriate prophylaxis is also high. … Patients received enoxaparin 40 mg/day for prophylaxis. … any prophylaxis,
adjusted for baseline risk of VTE. … In the base case, prophylaxis had an incremental cost of $44,091/QALY saved
compared with no prophylaxis … An observational study of the effectiveness of VTE prophylaxis, comparing patients who
received prophylaxis